PATENT CLAIM ANALYSIS

Application Number: 16068559
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["544", "331000"]

Abstract:
The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof and methods and compositions for treating or ameliorating abnormal cell proliferative disorders, such as cancer, wherein A, R 2 , R 3 , R 10 , E 1 , E 2 , E 3 , Y, and Z are as defined herein.

Claim (Index 147):
The method of  claim 146 , wherein the cancer results from a mutation in the exon 20 domain of EGFR.

Metadata:
- Claim Count in Document: 70.0
- Percentile: 95.0
- Lexical Diversity: 1.5098
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13229178', '12008840', '12842389', '11282119', '12310150']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8092902248763388
- 35 USC 102 Novelty (BERT): 0.523397831185621
- Combined Prediction Score: 0.7807009855072671
- Mean Citation Score: 314.529296
- Max Citation Score: 321.7707200000001
- Similarity Product: 188.8455848212624

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test